<DOC>
	<DOC>NCT01699581</DOC>
	<brief_summary>Nestle Impact has shown efficacy in multiple surgical trials in relation to improving hospital length of stay and infection rate. 1 dose of Nestle Impact Advanced Recovery will be taken orally three times a day beginning on the morning following stem cell transplant and will continue until the day of hospital discharge.</brief_summary>
	<brief_title>Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Patients receiving an autologous stem cell transplant using the preparative regimens of BEAM (Carmustine, Etoposide, Cytarabine, Melphalan), Melphalan 140mg/m2, or Melphalan 200mg/m2 Any prior diet or supplement will be allowed. Age &gt;18 years. Ability to understand and the willingness to sign a written informed consent document. History of allergic reactions attributed to compounds of similar chemical or biologic composition to Nestle Impact including fish oil.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hodgkin's Lymphoma</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Non-Hodgkin's Lymphoma</keyword>
</DOC>